• Български
  • English
  • Ελληνικά
  • Русский

Pancreas

HIFU TREATMENT CRITERIA FOR PATIENTS WITH PANCREATIC CANCER

INDICATIONS FOR HIFU - ABLATION

  • Histologically verified pancreatic cancer
  • The patient cannot withstand a radical surgery
  • Unresectable carcinoma
  • Expected survival for more than 3 months
  • The tumor is clearly visible with ultrasound
  • The patient has no clinical manifestations of obstructive jaundice
  • Possibility to provide enough and safe  acoustic approach to the  tumor
  • Patients in stage 4 with a strong pain syndrome of morphine derivatives
  • Patients have applied  at least 3 courses of chemotherapy before  the HIFU - ablation
  • Signed informed consent  for the  ablation

CONTRAINDICATIONS FOR HIFU - ABLATION:

  • Contraindications for general anesthesia
  • After surgery for  jaundice, the tumor is not visible with ultrasound due to large postoperative scars, adhesions etc.
  • The presence of metal particles (clips) after surgery / pankreatoektomiya /
  • Obstructive jaundice
  • Thrombosis of the inferior vena cava and / or portal vein Completely broken upper mesenteric vessels
  • Massive calcification of the vessels
  • Patients after radiotherapy with  a dose over 45 GY.

HAYFU treatment in patients with advanced pancreatic cancer

indication:

  • Histologically or cytologically proven pancreatic cancer
  • pancreatic cancer in which operation is not possible
  • A patient with a strong pain syndrome of morphine derivatives
  • A patient with a strong pain syndrome of morphine derivatives
  • 3 courses of chemotherapy before ablation
  • Patient preserved structural condition
  • Signed informed consent for ablation
  • A patient who can not withstand radical surgery
  • Patient not clinically manifested obstructive jaundice
  • A patient who has no leukocytosis
  • absolute contraindications:

    • After operations on the occasion of jaundice tumor is not visible by ultrasound
    • Great postoperative scarring limiting ablation, multiple adhesions, etc..
    • obstructive jaundice
    • Completely disabled or under 30% flow in the upper mesenteric vessels, truncus tseliakus, vein porter, etc.
    • Calcification of vessels
    • Patient after radiation therapy at a dose of 45 GY
    • data from computed tomography for thrombosis and arterial venous vessels in
    • Availability of leukocytosis
    • Poor general condition
    • Lack of histological and cytological evidence of pancreatic cancer

    elative contraindications:

    • Relative contraindications
    • Plastic bench at the common bile duct.
    • Infiltration of a hollow organ abdominal tumor
    • Obstructive jaundice
    • Lack of consultation with experienced hepatobiliary surgeon
These patients go through a committee of experienced professionals Hayfu
for their approval or rejection for conducting extracorporeal ablation
in advanced pancreatic cancer.